{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-017165","form_type":"8-K","ticker":"BBLG","cik":"0001419554","company_name":"Bone Biologics Corp","filed_at":"2025-06-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.240671+00:00","generated_at":"2026-05-18T12:31:13.951534+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Bone Biologics closes $5M public offering, net proceeds ~$4.3M","bullets":["Gross proceeds $5M from 1.25M shares (or pre-funded) plus Series D/E warrants; net ~$4.3M after fees.","Series D warrants (5-year, $4 strike) and Series E warrants (18-month, $4 strike); potential $10M if fully exercised.","Proceeds to fund clinical trials, patent portfolio, and working capital.","H.C. Wainwright acted as exclusive placement agent; fees 7% of gross plus 1% management fee.","After closing, approximately 1.6M shares of common stock outstanding."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-017165","json":"https://secwatch.observer/filing/0001641172-25-017165.json","markdown":"https://secwatch.observer/filing/0001641172-25-017165.md","text":"https://secwatch.observer/filing/0001641172-25-017165.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1419554/000164117225017165/0001641172-25-017165-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1419554/000164117225017165/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T12:31:13.951534+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}